CARA News and Press, Cara Therapeutics Inc. From 10/01/21

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

STAMFORD, Conn., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs), toda...

STAMFORD, Conn., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs), toda...

Cara Therapeutics (NASDAQ: CARA) recently scored a key win with Food and Drug Administration approval of Korsuva in treating pruritis associated with chronic kidney disease for patients on hemodialysis. In this Motley Fool Live video recorded on Aug. 25, 2021 , Motley Fool c...

Are These Top Health Care Stocks Worth Buying Now? You can’t deny that health care is one of, if not the most vital industries in the world today. As such, health care stocks would be among the hot stocks to buy in the stock market now. For one thing, there is plenty ...

Cara Therapeutics (NASDAQ: CARA) was a hot stock on Tuesday. One of the formerly clinical-stage biotech's drug candidates won FDA approval, and investors reacted in the usual manner. The shares rose by as much as 28% on the day before settling down to a sub-3% gain near market close...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Cara Therapeutics (NASDAQ: CARA ) stock are climbing higher on Tuesday following some positive news for one of its drugs on Monday afternoon. Source: luchschenF / Shutterstock.com According to the re...

Earnings season might be firmly in the rearview at this point, but quarterly results continued to drive single-stock moves in Tuesday's pre-market trading. Palo Alto Networks (NYSE:PANW) led the way, posting a double-digit percentage gain on its Street-beating financial figures. Best Buy (NYS...

Triple-S Management (NYSE:GTS) +44% to be acquired by GuideWell in an all-cash deal worth $900 million Bio-Path (NASDAQ:BPTH) +32% on FDA clearance of BP1002 application in acute myeloid leukemia Cara Therapeutics (NASDAQ:CARA) +21% and Vifor Pharma announce U.S. FDA ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re getting ready for another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday. Source: Shutterstock But hold on just a second. Before that, make ...